UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

EMBO molecular medicine, 2015-08, Vol.7 (8), p.1034-1047

2015

Volltextzugriff (PDF)

Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors

Scientific reports, 2022-03, Vol.12 (1), p.4696-4696, Article 4696

2022

Volltextzugriff (PDF)

Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study

Redox biology, 2021-11, Vol.47, p.102145-102145, Article 102145

2021

Volltextzugriff (PDF)

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

Proceedings of the National Academy of Sciences - PNAS, 2007-05, Vol.104 (18), p.7564-7569

2007

Volltextzugriff (PDF)

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma

The Journal of pathology, 2020-12, Vol.252 (4), p.384-397

2020

Volltextzugriff (PDF)

Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a

Science (American Association for the Advancement of Science), 2009-09, Vol.325 (5945), p.1261-1265

2009

Volltextzugriff (PDF)

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

BMC cancer, 2011-09, Vol.11 (1), p.418-418, Article 418

2011

Volltextzugriff (PDF)

NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics

Molecular oncology, 2017-04, Vol.11 (4), p.438-451

2017

Volltextzugriff (PDF)

p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes

Molecular cancer research, 2017-08, Vol.15 (8), p.1051-1062

2017

Volltextzugriff (PDF)

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

EMBO molecular medicine, 2020-10, Vol.12 (10), p.e12118-n/a

2020

Volltextzugriff (PDF)

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

Scientific reports, 2024-03, Vol.14 (1), p.6873-6873, Article 6873

2024

Volltextzugriff (PDF)

Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study

Journal of translational medicine, 2023-09, Vol.21 (1), p.1-658, Article 658

2023

Volltextzugriff (PDF)

Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study

Redox biology, 2023-07, Vol.63, p.102728-102728, Article 102728

2023

Volltextzugriff (PDF)

Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes

Molecular oncology, 2012-10, Vol.6 (5), p.494-506

2012

Volltextzugriff (PDF)

CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

BMC research notes, 2023-06, Vol.16 (1), p.105-9, Article 105

2023

Volltextzugriff (PDF)

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

Breast cancer research : BCR, 2015-09, Vol.17 (1), p.130-130, Article 130

2015

Volltextzugriff (PDF)

Molecular and genetic diversity in the metastatic process of melanoma

The Journal of pathology, 2014-05, Vol.233 (1), p.39-50

2014

Volltextzugriff (PDF)

Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer

Journal of translational medicine, 2023-10, Vol.21 (1), p.1-696, Article 696

2023

Volltextzugriff (PDF)

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

Nature medicine, 2001-06, Vol.7 (6), p.673-679

2001

Volltextzugriff (PDF)

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

JCO precision oncology, 2018-03 (2), p.1-18

2018

Volltextzugriff (PDF)

Autoimmunity to selenoprotein P predicts breast cancer recurrence

Redox biology, 2022-07, Vol.53, p.102346-102346, Article 102346

2022

Volltextzugriff (PDF)

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data

Genome Biology, 2002-07, Vol.3 (8), p.SOFTWARE0003-SOFTWARE0003, Article software0003.1

2002

Volltextzugriff (PDF)

Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma

Clinical cancer research, 2007-04, Vol.13 (7), p.1987-1994

2007

Volltextzugriff (PDF)

Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab

NPJ breast cancer, 2024-02, Vol.10 (1), p.14-14, Article 14

2024

Volltextzugriff (PDF)

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

NPJ breast cancer, 2022-08, Vol.8 (1), p.94-17, Article 94

2022

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(88)
Tagungsberichte
(9)

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors

Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma

Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics

p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes

The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

Matched analysis of circulating selenium with the breast cancer selenotranscriptome: a multicentre prospective study

Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study

Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes

CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

Molecular and genetic diversity in the metastatic process of melanoma

Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

Autoimmunity to selenoprotein P predicts breast cancer recurrence

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data

Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma

Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab

RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

Suchergebnisse filtern